. The first of these new resources will be employed in France,...

. The first of these new resources will be employed in France, with the specific
objective of engaging medical systems offering clinical testing and screening services via a
network of privately owned laboratories. We aim to approach several key laboratories to trial the
EuGeni platform to create momentum for further roll-out. Additionally, we will be undertaking the
required French clinical validation and aim to commence this in the coming weeks. We are also
finalising similar approaches to align with market and regulatory requirements in Germany, UK,
Italy and Spain